Check out our COVID-19 dedicated page for tenders related to medical equipment needs.

The Conference on the Future of Europe is your chance to share your ideas and shape the future of Europe. Make your voice heard!

Services - 351202-2016

08/10/2016    S195

France-Paris: Research and experimental development services

2016/S 195-351202

Prior information notice

This notice is for prior information only


Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: Groupement d'intéret public — Réseau des acheteurs hospitaliers (GIP Resah)
Postal address: 47 rue de Charonne
Town: Paris
NUTS code: FR101 Paris
Postal code: 75011
Country: France
Contact person: M. Louis Potel
Telephone: +33 761735053
Internet address(es):
Main address:
Address of the buyer profile:
I.1)Name and addresses
Official name: Uppsala Lans Landsting
Postal address: Slottsgrand 2ª
Town: Uppsala
NUTS code: SE121 Uppsala län
Postal code: 751 25
Country: Sweden
Contact person: M. Johan Lindqvist
Telephone: +46 705750417
Internet address(es):
Main address:
I.1)Name and addresses
Official name: Servicio Andaluz de Salud
Postal address: Avenida de la Constitución, 18
Town: Sevilla
NUTS code: ES618 Sevilla
Postal code: 41071
Country: France
Contact person: Carmen González
Telephone: +34 957213714
Internet address(es):
Main address:
Address of the buyer profile:
I.2)Information about joint procurement
The contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law:


The contract is awarded by a central purchasing body
Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity

Section II: Object

II.1)Scope of the procurement

Pre-commercial procurement (PCP) to buy research and development (R&D) services to improve chronic pain self-management through the development of innovative ICT solution(s) addressing actual need(s).

II.1.2)Main CPV code
73100000 Research and experimental development services
II.1.3)Type of contract
II.1.4)Short description:

Develop and test eHealth solutions for improving chronic pain self-management.

Priorities of intervention have been identified such as care coordination, assessment and measurement, self-management, monitoring, information and education. Although there is a wide range of high-tech devices aimed at treating pain, it is still necessary to cover the gap between Research and Commercialization. Only a small percentage of the existing solutions are clinically validated. A wide variety of ICT could provide solutions to this challenge.

RELIEF is mainly focused on technologies improving self-care, which go beyond the standard telecare and telehealth, virtual reality, augmented reality, apps, remote access to therapist, gamification, etc. These technologies could lead to personalized medicine and improve patient safety enhancing the efficiency of the public healthcare system.

II.1.5)Estimated total value
Value excluding VAT: 1 890 000.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2.3)Place of performance
Main site or place of performance:

France: FR;

Sweden: SE;

Spain: ES.

II.2.4)Description of the procurement:

RESAH will act as the lead procurer and will lead the joint procurement in the name and on behalf of CCU and SAS. The procurement will be a PCP under which R&D services contracts will be awarded to providers in parallel in a phased approach. Each selected operator will be awarded a framework agreement that cover 3 (three) R&D phases: phase A solution design, Phase B prototype development and Phase C pre-commercial development.

After each phase, intermediate evaluations will be carried out to progressively selecting the best of the competing solutions. The best-value-for-money solutions will be offered a specific contract for the next phase. Testing will be carry out in France, Sweden and Spain.

PCP Launch is expected in February 2017.

More details concerning the RELIEF PCP call and the procedure:

All Applications must be submitted at least in English and additionally can be submitted in French.

II.2.14)Additional information

Open Market Consultation (OMC) information will be available on the RELIEF website:

An online questionnaire will be available on the RELIEF website from the 1st November until 31st December and 3 specific Workshops will be held:

— France: Paris 1st December;

— Spain: Cordoba 14th December;

— Sweden: Uppsala 9th December.

II.3)Estimated date of publication of contract notice:

Section IV: Procedure

IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no

Section VI: Complementary information

VI.3)Additional information:

This procurement is funded by the European Union's Horizon 2020 Research and Innovation Programme, under grant agreement No 689476 RELIEF see:

The EU has given a grant for this procurement but is not participating in the procurement.

The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws implemented them (because it concerns the procurement of R&D services where the benefits do no accrue exclusively to the contracting authority for its use in the conduct of its own affairs).

This PIN is published to announce an open market consultation on a future procurement procedure. The PIN is not a commitment to procure.

You can participate in the PCP call for tender even if you do not participate in the open market consultation (OMC).

VI.5)Date of dispatch of this notice: